Ocugen (OCGN) Capital Leases (2018 - 2019)
Ocugen's (OCGN) quarterly Capital Leases came in at $17339.0 in Q3 2019, down 48.58% on a QoQ basis from $33720.0 in Q4 2018.
Ocugen (OCGN) Capital Leases (2018 - 2019) Analysis & Trends
Ocugen (OCGN) has 2 years of Capital Leases data on file, last reported at $17339.0 in Q3 2019.
- Quarterly Capital Leases changed N/A year-over-year to $17339.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $17339.0 (changed N/A YoY) and the FY2018 annual result came in at $33720.0, changed N/A from the prior year.
- Capital Leases fell to $17339.0 in Q3 2019, from $33720.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $33720.0 in Q4 2018 to a low of $17339.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 17,339.00 |
| Dec 31, 2018 | 33,720.00 |